Oracle — $ORCL
The Street sees $210+. The cash flow says earn it.
▶ Watch the full video breakdown — every table, the chart, and both flow prints in under 7 minutes
YouTube · OptionFlowTracker
The thesis
Oracle is no longer a sleepy mature software company. It has become a hybrid: a sticky, recurring software platform (more than 70% of revenue recurring or renewable) bolted to one of the most aggressive AI-infrastructure buildouts in the market. Remaining performance obligations stand at $638B, up 363% — roughly 9.5× annual revenue already under contract. That is real demand, not narrative. But the stock has been punished — a slide from roughly $251 to $140 — because the market has started asking what this growth costs. S&P cut the credit rating to BBB-, one notch above junk, and the backlog is concentrated in a handful of AI counterparties: if a customer renegotiates or can't find compute, a chunk of that $638B gets less bankable fast. This is now an execution story, a financing story, and a capital-allocation story all at once.
The growth the market is discounting
Revenue projection ($B)
FY26 actual; FY27–28 estimates per J.P. Morgan · ~37.5% 2-yr CAGR.
EPS projection ($, non-GAAP)
FY26 actual; estimates per J.P. Morgan · ~17.6% 2-yr CAGR.
The gap between the two CAGRs is the Oracle story — revenue rips while FY27 earnings absorb the buildout's bill, then EPS catches up in FY28.
Margins — the part we don't like
| Metric | FY2026 | FY2027E | FY2028E |
|---|---|---|---|
| Gross margin | 67.1% | 61.1% | 55.1% |
| EBIT margin | 42.9% | 38.2% | 35.0% |
| Net margin | 33.2% | 26.4% | 25.0% |
Falling margins during a hype cycle are always more dangerous than they look. (Estimates per J.P. Morgan.)
Balance sheet
| Metric | FY2026 | FY2027E | FY2028E |
|---|---|---|---|
| Long-term debt | ~$85B | ~$125B | ~$165B |
| Shareholders' equity | $20.5B | $42.2B | $44.9B |
| Debt / equity | 4.2× | 3.0× | 3.7× |
| Interest expense (our est.) | ~$5.8B | ~$6.5B | ~$8B+ |
| Working capital | Negative | Negative | Negative |
Strong business, stressed balance sheet — BBB- is the agencies saying the margin for error has narrowed. D/E improves in FY27 as the equity raise lands, then deteriorates again as debt outruns retained earnings. Interest expense estimates are ours, off Q4 FY26's $1.44B (+47% YoY) run-rate and rising debt.
Cash flow
| Metric | FY2026 | FY2027E | FY2028E |
|---|---|---|---|
| Operating cash flow | $25.2B | $29.9B | $39.0B |
| Capex (≈ total investing CF) | ($55.7B) | ($92.5B) | ($96.0B) |
| Free cash flow (FCFF) | ($29.6B) | ($58.1B) | ($52.4B) |
CFO minus capex — the FCF walk. Investing cash flow is almost entirely capex during the buildout; the single biggest issue with the bull case is contracted future revenue with zero near-term FCF support. (Estimates per J.P. Morgan.)
Our valuation — scenario analysis
| Scenario | FY27E EPS (vs consensus) | Forward P/E | Fair value | Anchors to |
|---|---|---|---|---|
| Bear | $7.70 (–4%) | 15.5× | ~$119 | our $120 technical floor |
| Base | $8.05 (in line) | 20× | ~$161 | our $155–160 recovery zone |
| Bull | $8.45 (+5%) | 26× | ~$220 | inside the Street's $210–245 |
Skew at $141.50: roughly $22 of modeled downside vs $20 base / $79 bull upside.
Model risk
This framework is only as good as its two inputs, and both carry unusual uncertainty. The EPS anchor: our drift band may be too kind — consensus leans on backlog conversion happening on schedule; if a major AI counterparty renegotiates or defers, FY27 EPS doesn't miss by 4%, it misses by far more, and the bear floor moves below $119 with it. Non-GAAP earnings also flatter the picture while free cash flow runs deeply negative: when earnings and cash diverge this widely, the multiple the market will pay becomes less predictable, not more. And the multiple itself: every 1× of P/E is worth about $8 on the stock, so the honest range around any scenario is wide. These scenarios are brackets, not probabilities — treat the table as a map of the debate, not a prediction of the destination.
Where the Street sits
| Firm | Date | Rating | Target | Basis |
|---|---|---|---|---|
| J.P. Morgan | Jun 10 | Overweight | $210 (Dec-26) | ~24× EV/CY27E GAAP op income |
| Evercore ISI | Jul 9 | Outperform | $245 | Deeply oversold at 17-year support |
| Value Line | May 1 | — | $124–$304 (mid $214) | 2029–31 projection $350–$525 |
| Consensus | — | Buy | $240–260 | Nobody disputes the demand |
The debate is entirely about what Oracle pays to capture it. Analyst targets attributed as publicly reported.
Technical read — the level map
| Level | Meaning |
|---|---|
| $195–200 | Where the chart broke |
| $165–170 | Upside room into end of July |
| $155–160 | First recovery zone if support holds |
| $135–140 | Line in the sand — weekly close only; spikes don't count |
| $120 | In play if the zone is lost |
Potential double/triple bottom at 17-year support, below all major moving averages — we're watching for a false breakdown below $140 that scares out weak hands, then reverses.
Beta — the stock changed character
| Window | Beta |
|---|---|
| 5-year (monthly) | 1.72 |
| 3-year | 2.26 |
| 2-year | 2.84 |
The AI pivot didn't just change the business — it changed the stock, from mature software (~1.7) to a leveraged AI trade (~2.8). R² of 0.35 means most of the movement is company-specific. OptionFlowTracker calculation, monthly total returns vs the S&P 500.
The tape is leaning bullish at the lows.
Fundamental
$638B backlog vs deeply negative near-term FCF and BBB- credit.
Technical
Below all major moving averages, testing 17-year support at $135–140.
Options Flow
Ask-side, opening call blocks on back-to-back sessions right at support.
| Metric | Jul 9 Print | Jul 10 Print |
|---|---|---|
| Contract | $143C · 07/31 | $140C · 07/24 |
| Premium | $2.39M + $1.54M follow-on | $1.86M |
| Size / Day volume | 2,547 / 2,549 | 2,570 · opening print |
| Fill | Block · At Ask | Block · At Ask |
| Confirmed the next morning | ✅ Verified | ✅ Verified |
On July 9, clustered ask-side buying hit the ORCL July $143 calls — $2.39M in one block, more behind it — and the tape confirmed underneath, pushing $144 → $148 intraday. Confirmed the next morning, before the open, as genuine new positioning. July 10 continued the pattern: a block of July $140 calls at the ask, right at the money, opening well beyond anything already standing in the strike and confirmed the next morning — two for two. Short-dated and near the money — a bet on the move landing soon, not eventually. Ask-side, opening, near-the-money call blocks on back-to-back sessions at 17-year support is precisely the confluence our framework looks for. Research and education, not financial advice.
Insiders
Neutral to mildly negative. No clustered open-market buys signaling conviction, but no discretionary panic-selling to read as bearish either.
Key risks
Backlog concentration in a few AI counterparties — if a customer renegotiates or can't find compute, a chunk of the $638B gets less bankable fast. A funding plan with no room for a demand air-pocket (long-term debt toward ~$165B by FY28E, BBB-, negative free cash flow throughout). Margin compression to ~55% gross. Negative working capital. A rising beta in a market re-rating AI-infrastructure multiples. And a weekly close below $135–140 opens the door to $120.
Bottom line
Great business momentum. Weak current cash economics. Much higher execution risk than software investors are used to. The company is stronger than the stock narrative suggests — but the stock carries more risk than a simple forward P/E makes it look. If Oracle converts this capex wave into durable OCI revenue and normalizes free cash flow, today's ~$141 looks cheap against our base case of ~$161, our bull case of ~$220, and the Street's $210–245. If revenue slips first, the punishment comes fast — there's no cash-flow cushion. Tactical accumulation, not relaxed buy-and-hold — for risk-tolerant investors only. What we're watching: OCI growth durability, capex discipline, backlog conversion, funding needs, and the $135–140 weekly close. Research and education only — not a recommendation; size and manage risk to your own plan.
Every Friday's weekly close vs the $135–140 line · Q1 FY27 earnings (September) · AI-counterparty headlines · morning-after confirmation on new flow prints.
Want research like this on the major names, every week? Stock Research Pro is coming — $150/mo at launch; founding members lock in $99/mo forever. Join the waitlist →
Get the next research note free
One option-flow breakdown and a recap of last week — every week, free.
Always free · No credit card · Unsubscribe anytime
Research and education only. Not financial advice, and not a recommendation to buy or sell any security. Company figures reflect OptionFlowTracker's own estimates and analysis; third-party price targets are as publicly reported. Analyst ratings and price targets are attributed to their respective firms as publicly reported and are not our recommendations.